Have a personal or library account? Click to login
How well are clinical gross tumor volume DVHs approximated by an analytical function? Cover

How well are clinical gross tumor volume DVHs approximated by an analytical function?

Open Access
|Jun 2009

References

  1. Ebert MA. Viability of the EUD and TCP concepts as reliable dose indicators. Phys Med Biol 2000; 45: 441-57.10.1088/0031-9155/45/2/313
  2. Stavrev P, Schinkel C, Stavreva N, Warkentin B, Fallone B. Population TCP estimators in case of heterogeneous irradiation. Radiother Oncol 2007; 84: S279-S80.
  3. Nahum AE, Sanchez-Nieto B. Tumour control probability modelling: basic principles and applications in treatment planning. Physica Medica 2001; XVII(Suppl 2): 13-23.
  4. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002; 52: 224-35.10.1016/S0360-3016(01)02585-8
  5. De Gersem WR, Derycke S, Colle CO, De Wagter C, De Neve WJ. Inhomogeneous target-dose distributions: a dimension more for optimization? Int J Radiat Oncol Biol Phys 1999; 44: 461-8.10.1016/S0360-3016(98)00464-7
  6. De Gersem WR, Derycke S, De Wagter C, De Neve WC. Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio. Int J Radiat Oncol Biol Phys 2000; 47: 255-60.10.1016/S0360-3016(99)00332-6
  7. Mohan R, Mageras GS, Baldwin B, Brewster LJ, Kutcher GJ, Leibel S, et al. Clinically relevant optimization of 3-D conformal treatments. Med Phys 1992; 19: 933-44.10.1118/1.596781
  8. Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant WH 3rd, Lu HH, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 2001; 49: 705-12.10.1016/S0360-3016(00)01428-0
  9. Reinstein LE, Wang XH, Burman CM, Chen Z, Mohan R, Kutcher G, et al. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 1998; 40: 207-14.10.1016/S0360-3016(97)00582-8
  10. Stanescu T, Hans-Sonke J, Stavrev P, Fallone B. 3T MR-based treatment planning for radiotherapy of brain lesions. Radiol Oncol 2006; 40: 125-32.
  11. Bos LJ, Damen EMF, DeBoer RW, Mijnheer BJ, McShan DL, Fraass BA, et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys 2002; 52: 254-65.10.1016/S0360-3016(01)02676-1
  12. Nederveen AJ, VanderHeide UA, Hofman P, Welleweerd H, Lagendijk JJW. Partial boosting of prostate tumours. Radiother Oncol 2001; 61: 117-26.10.1016/S0167-8140(01)00405-4
  13. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensitymodulated techniques. Radiother Oncol 2001; 60: 157-63.10.1016/S0167-8140(01)00438-8
  14. Ólafsson A, Jeraj R, Wright SJ. Optimization of intensity-modulated radiation therapy with biological objectives. Phys Med Biol 2005; 50: 5357-79.10.1088/0031-9155/50/22/01016264258
  15. Stavrev P, Stavreva N, Schinkel C, Fallone B. An objective function for TCP/NTCP curve fitting. Med Phys 2007; 34: 2417-8.10.1118/1.2760725
DOI: https://doi.org/10.2478/v10019-009-0016-x | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 132 - 135
Published on: Jun 8, 2009
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Pavel Stavrev, Colleen Schinkel, Nadia Stavreva, B. Falloned, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 2 (June 2009)